G N Ioannou
Overview
Explore the profile of G N Ioannou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OHare A, Berry K, Fan V, Crothers K, Eastment M, Dominitz J, et al.
BMC Geriatr
. 2021 Jul;
21(1):415.
PMID: 34229623
Background: Older age and comorbid burden are both associated with adverse outcomes in SARS-CoV-2, but it is not known whether the association between comorbid burden and adverse outcomes differs in...
2.
Johnson K, Green P, Ioannou G
J Viral Hepat
. 2017 Jun;
24(11):966-975.
PMID: 28585416
We aimed to determine whether the HCV viral load after four weeks of treatment (W4VL) with direct-acting antiviral agents (DAAs) predicts sustained virologic response (SVR) in a real-world clinical setting....
3.
Moon A, Green P, Berry K, Ioannou G
Aliment Pharmacol Ther
. 2017 Mar;
45(9):1201-1212.
PMID: 28271521
Background: Highly effective direct antiviral agents (DAAs) for hepatitis C virus (HCV) were introduced recently. Their utilisation has been limited by high cost and low access to care. Aim: To...
4.
Ioannou G, Scott J, Yang Y, Green P, Beste L
Aliment Pharmacol Ther
. 2013 Oct;
38(11-12):1373-84.
PMID: 24127691
Background: The effectiveness of anti-viral treatment for hepatitis C virus (HCV) in HIV/HCV co-infected patients in 'real world', clinical practice is unclear. Aims: To determine the rates and predictors of...
5.
Berry K, Ioannou G
Am J Transplant
. 2011 Nov;
12(3):706-17.
PMID: 22123435
We aimed to estimate the survival benefit derived from transplantation in patients with stage II hepatocellular carcinoma (HCC) and Child's A cirrhosis, defined as the mean lifetime with transplantation minus...
6.
Ioannou G, Liou I, Weiss N
Aliment Pharmacol Ther
. 2006 May;
23(11):1637-42.
PMID: 16696814
Background: Bilirubin has antioxidant properties and has been postulated to protect against the development of malignancies. Aim: To investigate whether baseline serum bilirubin concentration predicts the incidence of colorectal cancer...
7.
Ioannou G, Weiss N, Kearney D
Aliment Pharmacol Ther
. 2005 Mar;
21(6):765-72.
PMID: 15771763
Background: Helicobacter pylori infection may decrease serum ghrelin and increase gastric leptin levels, which may, in turn, decrease body mass index. Aim: To determine whether H. pylori seropositivity is associated...
8.
Ioannou G, Doust J, Rockey D
Aliment Pharmacol Ther
. 2002 Dec;
17(1):53-64.
PMID: 12492732
Background: Controversy exists surrounding pharmacological therapy in acute variceal bleeding. Aim: To determine the efficacy and safety of terlipressin. Methods: Randomized trials were identified and duplicate, independent, review identified 20...